Cysteamine clinical trials
Also written RP103, PROCYSBI® and Cystagon.
How each study uses Cysteamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Cysteamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 15 Aug 1994 · CYSTAGON · NDA 020392 (FDA, Drugs@FDA)
- European Union
- 23 Jun 1997 · Cystagon · EMEA/H/C/000125 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 16
Amgen (7) · National Eye Institute (NEI) (2) · Hasanuddin University (1) · Recordati Rare Diseases (1) · China Medical University Hospital (1) · Children's Hospital Medical Center, Cincinnati (1) · NovaBiotics Ltd. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)
Often tested with
Tested in the same studies.
Gamma-Aminobutyric Acid (1) · Deanol (1) · Bakuchiol (1) · Zidovudine (1) · Lopinavir-ritonavir drug combination (1) · Hydroxychloroquine (1) · Lopinavir (1) · Ritonavir (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Cysteamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 26
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingPhase 3UMC UtrechtNCT02735707Written as Cysteamine
- Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-AgingCompletedPhase 2Hasanuddin UniversityNCT07477288Written as Cysteamine
- Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With CystinosisCompletedPhase 3AmgenNCT01744782Written as RP103
- Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial DiseaseCompletedPhase 2AmgenNCT02023866Written as Cysteamine Bitartrate
- Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in CystinosisCompletedPhase 3AmgenNCT01733316Written as RP103
- Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)CompletedPhase 3AmgenNCT01197378Written as Cysteamine Bitartrate Delayed-release Capsules
- A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial DiseaseTerminatedPhase 2AmgenNCT02473445Written as Cysteamine Bitartrate
- Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With CystinosisCompletedPhase 1/2AmgenNCT00872729Written as Cystagon®
- Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With CystinosisCompletedPhase 3AmgenNCT01000961Written as Cystagon® (Cysteamine Bitartrate)
- Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)CompletedPhase 3Recordati Rare DiseasesNCT04125927Written as Mercaptamine
- Cysteamine Compared to Hydroquinone in MelasmaCompletedPhase 3China Medical University HospitalNCT05969587Written as 5% cysteamine cream
- Efficacy and Safety of Topical Cysteamine for Postinflammatory HyperpigmentationStatus unknownNot applicableChang Gung Memorial HospitalNCT05206318Written as Topical Cysteamine
- Cysteamine for AsthmaCompletedPhase 1Children's Hospital Medical Center, CincinnatiNCT03883984Written as Cysteamine Bitartrate
- A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis ExacerbationsCompletedPhase 2NovaBiotics Ltd.NCT03000348Written as Cysteamine
- Cysteamine Therapy for Major Depressive DisorderTerminatedNot applicableIcahn School of Medicine at Mount SinaiNCT00715559Written as cysteamine bitartrate
- Cystagon to Treat Infantile Neuronal Ceroid LipofuscinosisCompletedPhase 4Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00028262Written as Cystagon
- Efficacy of Topical Cysteamine in Nephropathic CyctinosisCompletedNot applicableThe Eye Center and The Eye Foundation for Research in OphthalmologyNCT02766855Written as Cysteamine
- First Study of Oral Cysteamine in Cystic FibrosisCompletedPhase 1/2University of AberdeenNCT02212431Written as Cysteamine
- Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With CystinosisCompletedNot applicableFDA Office of Orphan Products DevelopmentNCT00010426Written as cysteamine hydrochloride
- An Open Trial of Cysteamine Treatment in SchizophreniaTerminatedNot applicableAugusta UniversityNCT01139125Written as (Cystagon) Cysteamine Bitartrate
See all 26 studies that test Cysteamine →
As the comparator · 1 — what is tested is compared with Cysteamine
Codes
What other systems call Cysteamine · ClinicalTrials.gg INT007287
- MeSH (NLM) D003543CysteamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5UX2SD1KE2CYSTEAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 3022Confirmed FDA, Wikidata
- Wikidata Q617563cysteamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61696CysteamineOne source FDA
- DrugBank DB00847One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003543 | Cysteamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5UX2SD1KE2 | CYSTEAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3022 | — | Confirmed FDA, Wikidata |
| Wikidata | Q617563 | cysteamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61696 | Cysteamine | One source FDA |
| DrugBank | DB00847 | — | One source Wikidata |
Also registered as cysteamine bitartrate (UNII QO84GZ3TST · RxNorm 81990) and cysteamine hydrochloride (UNII IF1B771SVB · RxNorm 1426886).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.